Brinker Capital Investments’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Buy
+1,748
New +$215K ﹤0.01% 1738
2026
Q1
– Sell
-1,409
Closed -$231K – 2213
2025
Q4
$231K Buy
+1,409
New +$221K ﹤0.01% 1941
2022
Q3
– Sell
-1,816
Closed -$295K – 1381
2022
Q2
$295K Buy
1,816
+339
+23% +$53.6K 0.01% 1171
2022
Q1
$278K Sell
1,477
-237
-14% -$45K ﹤0.01% 1251
2021
Q4
$454K Buy
1,714
+1
+0.1% +$269 0.01% 1097
2021
Q3
$342K Hold
1,713
– – 0.01% 1096
2021
Q2
$342K Buy
1,713
+34
+2% +$6.6K ﹤0.01% 1150
2021
Q1
$326K Sell
1,679
-1,411
-46% -$289K ﹤0.01% 1031
2020
Q4
$592K Buy
3,090
+1,594
+107% +$290K 0.01% 806
2020
Q3
$221K Buy
+1,496
New +$214K ﹤0.01% 1085

Other funds holding RGEN

Brinker Capital Investments's RGEN Position: Q2 2026 in Review

Brinker Capital Investments opened a new position in Repligen (RGEN) in Q2 2026: 1,748 shares worth $238K. The stake represents ﹤0.01% of the portfolio and ranks #1738 among its holdings. This is a return to the name: Brinker Capital Investments previously reported a position in RGEN as recently as Q4 2025.

Brinker Capital Investments first reported a position in RGEN in Q3 2020 and has held it in 10 quarters since. The position peaked at $592K in Q4 2020. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Brinker Capital Investments held 1,748 shares of Repligen worth $238K as of Q2 2026.
  • Repligen was a new Brinker Capital Investments position in Q2 2026.
  • Repligen made up ﹤0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1738 holding.
  • Brinker Capital Investments first reported a position in Repligen in Q3 2020 and has held it in 10 quarters since.
  • Brinker Capital Investments's Repligen position peaked at $592K in Q4 2020.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.